| # | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. |  ALA4539943 | EUB0000725 | % of control | = | 43 | % | ALA5213652 | % | Homo sapiens | |||
| 2. |  ALA4206831 | 2; FMF-03-145-1 | Activity | = | 70 | % | ALA4186052 | % | Homo sapiens | |||
| 3. |  ALA3969370 | 19; FMF-01-086-2 | Activity | = | 93 | % | ALA4186052 | % | Homo sapiens | |||
| 4. |  ALA4174988 | 15i | Activity | = | 100 | % | ALA4157273 | % | Homo sapiens | |||
| 5. |  ALA4080797 | 35 | Activity | = | 62 | % | ALA4054926 | % | Homo sapiens | |||
| 6. |  ALA4096145 | 2 | Activity | = | 41 | % | ALA4054926 | % | Homo sapiens | |||
| 7. |  ALA4092508 | 2t | Activity | = | 100 | % | ALA4044194 | % | Homo sapiens | |||
| 8. |  ALA4533018 | IM-93 | Activity | = | 98 | % | ALA4308050 | % | Homo sapiens | |||
| 9. |  JSH-150 | 40; JSH-150 | Activity | = | 89 | % | ALA4264541 | % | Homo sapiens | |||
| 10. |  PDGFRα kinase inhibitor 1 | 15i | Activity | = | 72 | % | ALA4230952 | % | Homo sapiens | |||
| 11. |  ALA4077123 | 9; CHMFL-BTK-01 | Activity | = | 77 | % | ALA4025383 | % | Homo sapiens | |||
| 12. |  ALA4559936 | (+/-)-6 | Activity | = | 100 | % | ALA4391583 | % | Homo sapiens | |||
| 13. |  ALA4564973 | 50 | INH | = | 100 | % | ALA4389957 | % | Homo sapiens | |||
| 14. |  ALA4555459 | 43 | INH | = | 100 | % | ALA4389480 | % | Homo sapiens | |||
| 15. |  ALA4473365 | 7c | Activity | = | 23 | % | ALA4382761 | % | Homo sapiens | |||
| 16. |  ALA2348350 | 15u | Activity | = | 100 | % | ALA4806770 | % | Homo sapiens | |||
| 17. | ALA2348350 | 15u | Activity | = | 95 | % | ALA4806770 | % | Homo sapiens | |||
| 18. |  Meisoindigo | 2 | Activity | = | 100 | % | ALA4806206 | % | Homo sapiens | |||
| 19. |  ALA4870304 | IV | Activity | = | 97 | % | ALA4805753 | % | Homo sapiens | |||
| 20. |  ALA4878072 | Senexin C/6148/GJ-2331/2335 | Activity | = | 91 | % | ALA4805165 | % | Homo sapiens |
The page will load shortly, Thanks for your patience!